CD4 <sup>+</sup> Memory Stem‐Cell T Lymphocyte Frequency Is a Marker of Alloreactivity and a Predictor of Long‐Term Morbidity and Mortality After Hematopoietic Cell Transplantation
CD4<sup>+</sup> SCM frequency is a potential biomarker of allogeneic immune response intensity and cGvHD risk in the early posttransplantation period.
Authors
- Petra Hadlová
- Renata Formánková
- Petra Keslová
- Michaela Nováková (ORCID: https://orcid.org/0000-0003-2964-5956)
- Petr Říha
- Tomáš Kalina (ORCID: https://orcid.org/0000-0003-4475-2872)
- Iveta Janotová
Institutions
- Charles University (CZ)
- University Hospital in Motol (CZ)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2025-11-06
- DOI
- https://doi.org/10.1002/pbc.32144
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00